Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women

Sexually Transmitted Diseases

Volumn 38, Issue 7, 2011, Pages 587-597

  Kim, Soyeon ^a   Arduino, Jean Marie ^b   Roberts, Christine C ^b   Marsico, Mark ^b   Liaw, Kai Li ^b   Skjeldestad, Finn Egil ^c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHLAMYDIA TRACHOMATIS; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; NORWAY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PROSPECTIVE STUDY; RISK ASSESSMENT; SEXUAL INTERCOURSE;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CONDYLOMATA ACUMINATA; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 6; HUMANS; INCIDENCE; NORWAY; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79959655308     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31820a9324     Document Type: Article

References (25)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-265. (Pubitemid 34293391)
2. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153-156. (Pubitemid 32911406)
3. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 2007; 121:621-632. (Pubitemid 46986496)
4. Gross G, Ikenberg H, Gissmann L, et al. Papillomavirus infection of the anogenital region: Correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol 1985; 85:147-152. (Pubitemid 15007101)
5. Clarke P, Ebel C, Catotti DN, et al. The psychosocial impact of human papillomavirus infection: Implications for health care providers. Int J STD AIDS 1996; 7:197-200. (Pubitemid 26191688)
6. Maw R. Critical appraisal of commonly used treatment for genital warts. Int J STD AIDS 2004; 15:357-364. (Pubitemid 38797439)
7. Skjeldestad FE, Mehta V, Sings HL, et al. Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: Study design and cohort characteristics. Acta Obstet Gynecol Scand 2008; 87:81-88.
8. Roberts CC, Liaw KL, Skjeldestad FE, et al. Importance of specimen type in detecting human papillomavirus DNA from the female genital tract. J Med Virol 2009; 81:1620-1626.
9. Roberts CC, Tadesse AS, Sands J, et al. Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays. J Clin Virol 2006; 36:277-282. (Pubitemid 44088487)
10. Skjeldestad FE, Marsico MA, Sings HL, et al. Incidence and risk factors for genital Chlamydia trachomatis infection: A 4-year prospective cohort study. Sex Transm Dis 2009; 36:273-279.
11. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-2119. (Pubitemid 34437346)
12. Dias D, Van Doren J, Schlottmann S, et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16. Clin Diagn Lab Immunol 2005; 12:959-969.
13. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2006.
14. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354:2645-2654.
15. Villa LL, Costa RL, Petta CA, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/ 16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 2006; 95:1459-1466. (Pubitemid 44863348)
16. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-428. (Pubitemid 28135669)
17. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003; 12:485-490. (Pubitemid 36713640)
18. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 2001; 357:1831-1836. (Pubitemid 32539115)
19. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 2002; 186:462-469. (Pubitemid 34876254)
20. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001; 285:2995-3002. (Pubitemid 32550118)
21. Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-226. (Pubitemid 36152435)
22. Samoff E, Koumans EH, Markowitz LE, et al. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 2005; 162:668-675. (Pubitemid 41437366)
23. Madeleine MM, Anttila T, Schwartz SM, et al. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 2007; 120: 650-655. (Pubitemid 44969037)
24. Groseclose SL, Zaidi AA, DeLisle SJ, et al. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1999; 26:339-344. (Pubitemid 29296353)
25. van de Laar MJ, Morre SA. Chlamydia: A major challenge for public health. Euro Surveill 2007; 12:E1-E2.